Shanghai Haohai Biological Technology Salute del bilancio
Salute finanziaria criteri di controllo 5/6
Shanghai Haohai Biological Technology ha un patrimonio netto totale di CN¥6.0B e un debito totale di CN¥423.7M, che porta il suo rapporto debito/patrimonio netto a 7%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥7.2B e CN¥1.2B. L'EBIT di Shanghai Haohai Biological Technology è CN¥404.8M rendendo il suo rapporto di copertura degli interessi -6.4. Ha liquidità e investimenti a breve termine pari a CN¥2.7B.
Informazioni chiave
7.0%
Rapporto debito/patrimonio netto
CN¥423.70m
Debito
| Indice di copertura degli interessi | -6.4x |
| Contanti | CN¥2.69b |
| Patrimonio netto | CN¥6.03b |
| Totale passività | CN¥1.21b |
| Totale attività | CN¥7.25b |
Aggiornamenti recenti sulla salute finanziaria
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25
Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Recent updates
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All
May 22Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price
May 08Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Apr 19Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Mar 04Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 03Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?
Jan 10Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Oct 08Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly
Jul 07Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%
May 27These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Apr 04Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%
Mar 16Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( CN¥3.7B ) di 6826 superano le sue passività a breve termine ( CN¥861.5M ).
Passività a lungo termine: Le attività a breve termine di 6826 ( CN¥3.7B ) superano le sue passività a lungo termine ( CN¥350.6M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 6826 ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di 6826 è aumentato da 0.7% a 7% negli ultimi 5 anni.
Copertura del debito: Il debito di 6826 è ben coperto dal flusso di cassa operativo ( 159% ).
Copertura degli interessi: 6826 matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.